GlassScriptPhysician profile
Sara Metzger
NPI 1437453354
$4,054.34
in general payments reported to CMS, 2019-2025
10 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $705 · 2022: $1,097 · 2023: $1,263 · 2024: $497 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,242 · Education: $10.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.76 |
| Education | $10.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,775.81 | 2021-2025 | Yeztugo, Biktarvy |
| Viiv Healthcare Company | $1,183.28 | 2021-2025 | Dovato, Rukobia, Apretude |
| Abbvie INC. | $311.02 | 2021-2023 | |
| Alkermes, INC. | $228.00 | 2023-2025 | Vivitrol, Vivitrol |
| Merck Sharp & Dohme LLC | $223.32 | 2021-2025 | Pifeltro, Delstrigo, Capvaxive |
| Janssen Biotech, INC. | $144.37 | 2023 | Prezcobix |
| Janssen Products, LP | $111.86 | 2023 | Symtuza |
| Theratechnologies INC. | $50.48 | 2022-2024 | Trogarzo, Egrifta |
| Braeburn INC. | $15.46 | 2024 | Brixadi |
| Janssen Pharmaceuticals, INC | $10.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Metzger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.